A study has revealed that in the next decade. India is well positioned in the pharamaceutical sector, as a producer, exporter, and a consumer.

The study also said that the country is registering strong growth in the manufacturing of medical devices and is expected to grow at an estimated rate of approximately 12 per cent in 2011-12.

DHL, in association with, Organisation of Pharmaceutical Producers of India (OPPI), revealed findings from the study 'Transforming Life Sciences Logistics in India'.

The study delves into the competitive landscape of the life sciences industry and analyzes how logistics can be a crucial enabler of the growing life sciences segment in India.

Developed jointly by a team of DHL and OPPI professionals, the study focuses the spotlight on fundamental issues and offers solution ideas with thought leadership, said a press release.  

Christoph Remund, CEO - DHL Global Forwarding India said, 'India is well positioned in the Life Sciences and Healthcare sector both as a producer and as a consumer of pharmaceuticals.

In this study we closely examine India’s life sciences logistics setup and benchmark these against the best practices prevailing across the globe. Thus we are providing a realistic roadmap for India’s growth and progress in the life sciences logistics sector in the future.'